Oral cancer is the uncontrolled growth of the oral mucosa cells affecting the oral cavity. The global oral cancer treatment market is anticipated to generate a CAGR of 7.1% during the forecast period.
Growing prevalence and incidence of oral cancer coupled with the growing risk factors such as tobacco and betel nut use, presence of carcinogens in food products are the critical drivers of the market. According to the Oral Cancer Foundation, approximately 49,750 Americans were diagnosed with oral cancer resulting in 9,750 deaths in 2016. Thus oral cancer kills one patient every 24 hours. The high reimbursement and Medicaid spending is another driver of the market. Further the Centres for Disease Control and Prevention, estimates that the total healthcare expenditure of the U.S. in 2015 accounted for 17.8% of the total gross domestic product (GDP), representing USD 3.2 trillion.
FREE SAMPLE COPY OF “Oral Cancer Market Research Report- Global forecast till 2023” @ https://www.marketresearchfuture.com/sample_request/1820
Poor efficacy and efficiency of treatment, recurrence risks, surgical risks and related side effects followed by high cost of treatment are critical restraints of the market. For example, Dharamshila Hospital, India estimates the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979 in 2015.
Dominant players for global oral cancer treatment market:
The dominant players for the global oral cancer treatment market are Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Qilu Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd., Merck & Co., Inc. and others
The global oral cancer treatment market is segmented on the basis of type, treatment, end users and regions to get an accurate assessment of the differential potential of the market across these segments.
Type – squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others. Squamous cell carcinoma dominates the market by type.
Treatment – surgery (tumor resection, glossectomy, laryngectomy, mohs micrographic surgery, and others), radiotherapy, chemotherapy (cisplatin, carboplatin, 5-fluorouracil (5-FU), and others), and photodynamic therapy (PDT), and others.
End users – hospitals & clinics, research organization, academic institutes, and others.
Inquire Here For Queries Or Report Customization: https://www.marketresearchfuture.com/enquiry/1820
The Americas dominates the global oral cancer treatment market on account of well-developed healthcare sector, high expenditure on healthcare, excellent insurance penetration and high per capita income of the U.S.
Europe is the second largest market for oral cancer treatment led by Germany, France and the U.K. Well-developed healthcare infrastructure, large patient population, high per capita income and others drives the European market growth. The Cancer Research U.K, estimates 11,449 new cases of oral cancer resulting in 2,386 estimated death in 2015.
Asia Pacific is expected to be the fastest growing region riding the huge patient population, growing income and developing economies like India and China.
The Middle East & Africa market is expected to result in moderate growth with the lowest market share in the global oral cancer treatment market. The poor economies and social conditions coupled with smaller population base is constraining the market. The gulf economies such as Saudi Arabia, UAE and others are driving the market.
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/oral-cancer-treatment-market-1820
May, 2017 – Vigilant Biosciences launched OncAlert oral cancer rapid tests for the early detection and diagnosis of oral cancer
June 2017 – Norgine B.V. launched radiopharmaceutical LYMPHOSEEK (technetium Tc 99m) in Denmark, the Netherlands and the UK.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar